Mucoadhesive-to-penetrating controllable peptosomes-in-microspheres co-loaded with anti-miR-31 oligonucleotide and Curcumin for targeted colorectal cancer therapy
Mucoadhesive-to-penetrating controllable peptosomes-in-microspheres co-loaded with anti-miR-31 oligonucleotide and Curcumin for targeted colorectal cancer therapy
复制标题
粘膜粘附渗透性可控微球蛋白体共载抗 miR-31 寡核苷酸和姜黄素用于靶向结直肠癌治疗
DOI:
10.7150/thno.40318
复制
发表时间:
2020-02
期刊:
影响因子:
12.4
通讯作者:
Yu Zhengquan
中科院分区:
文献类型:
--
作者:
Zhao Ran;Du Sujuan;Liu Ying;Lv Cong;Song Yongli;Chen Xinchun;Zhang Bing;Li Dan;Gao Shan;Cui Wei;Plikus Maksim V;Hou Xiaohua;Wu Kaichun;Liu Zhanju;Liu Zhihua;Cong Yingzi;Li Yuan;Yu Zhengquan
Background: Accumulating evidences indicate that nanomedicines greatly decrease the side effects and enhance the efficacy of colorectal cancer (CRC) treatment. In particular, the use of rectal delivery of nanomedicines, with advantages such as fast therapeutic effects and a diminishing hepatic first-pass effect, is currently emerging. Method: We established a CRC targeted delivery system, in which α-lactalbumin peptosomes (PSs) co-loaded with a microRNA (miR)-31 inhibitor (miR-31i) and curcumin (Cur) were encapsuslated in thiolated TEMPO oxidized Konjac glucomannan (sOKGM) microspheres, referred as sOKGM-PS-miR-31i/Cur. The CRC targeting capability, drug release profiles, mucoadhesive-to-penetrating properties and therapeutic efficacy of sOKGM-PS-miR-31i/Cur delivery system were evaluated in colorectal cancer cells and azoxymethane-dextran sodium (AOM-DSS) induced tumor models. Results: sOKGM-PS-miR-31i/Cur delivery system were stable in the harsh gastrointestinal environment after rectal or oral administration; and were also mucoadhesive due to disulfide bond interactions with the colonic mucus layer, resulting in an enhanced drug retention and local bioavailability in the colon. Concomitantly, the released PS-miR-31i/Cur PSs from the microsphere was mucus-penetrating, efficiently passing through the colonic mucus layer, and allowed Cur and miR-31i specifically target to colon tumor cells with the guide of CD133 targeting peptides. Consequently, rectal delivery of sOKGM-PS-miR-31i/Cur microspheres suppressed tumor growth in an azoxymethane-dextran sodium sulfate (AOM-DSS)-induced tumor model. Conclusion: sOKGM-PS-miR-31i/Cur microspheres are effective rectal delivery system with combined advantages of mucoadhesive and mucus-penetrating properties, representing a potent and viable therapeutic approach for CRC.
登录
查看更多内容
影响因子:
12.4
作者:
Liu X;Li Y;Sun X;Muftuoglu Y;Wang B;Yu T;Hu Y;Ma L;Xiang M;Guo G;You C;Gao X;Wei Y
通讯作者:
Wei Y
影响因子:
9.5
作者:
Wei Liang;Wu Shaohua;Shi Wen;Aldrich Amy L;Kielian Tammy;Carlson Mark A;Sun Runjun;Qin Xiaohong;Duan Bin
通讯作者:
Duan Bin
影响因子:
--
作者:
Principe DR;DeCant B;Staudacher J;Vitello D;Mangan RJ;Wayne EA;Mascariñas E;Diaz AM;Bauer J;McKinney RD;Khazaie K;Pasche B;Dawson DW;Munshi HG;Grippo PJ;Jung B
通讯作者:
Jung B
影响因子:
16.1
作者:
Lai, Samuel K.;Wang, Ying-Ying;Hanes, Justin
通讯作者:
Hanes, Justin
影响因子:
3.3
作者:
Sun, Yingnan;Shen, Shourong;Li, Xiayu
通讯作者:
Li, Xiayu